<http://webisa.webdatacommons.org/150457821>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/383674557>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/150457821> .
<http://webisa.webdatacommons.org/150457821>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<thestockmarketwatch.com> .
<http://webisa.webdatacommons.org/prov/83757922>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/150457821> .
<http://webisa.webdatacommons.org/prov/184680226>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/150457821> .
<http://webisa.webdatacommons.org/150457821>	<http://www.w3.org/ns/prov#value>	"MannKind Corporation is a biopharmaceutical company, which is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.Interactive Intelligence Inc. (NASDAQ:ININ) is currently tra" .